Cancer grading is part of breast cancer staging and is an indicator of the the aggressiveness of breast cancer. Breast cancer staging is not solely based on the grade of the tumor.Other factors include thesize and locationof the tumor, the number oflymph nodesaffected, and the degree ofmetast...
breast cancergradehormoneHistological tumor grade is a well-established marker of breast tumor aggressiveness and prognosis. A number of reproductive factors, including parity and age at first birth, have been shown to be related to breast cancer risk, but few studies have examined the association ...
Cancer stagingis the process of determining how muchcanceris within the body (tumor size) and if it has spread. Forbreast cancer, this might take the form of clinical (pre-surgical) staging or pathologic (surgical) staging. Breast cancer is classified by stages. There are five stages of bre...
Breast cancerDopplerEstrogen receptorsBiological tumor markersVascular factorThis study aimed to investigate the three-dimensional (3-D) power Doppler ultrasonographic (PDUS) vascular features of breast carcinoma according to intrinsic subtypes, nodal stage, and tumor grade. Total 115 receiving mastectomy ...
The purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 subtypes with survival of an immunohistochemical surrogate for the molecular subtype based on the ER/PR/HER2 subtypes and tumor grade. Methods. We identified 123,780 cases of stages 1–3 primary ...
There was a direct correlation between RyR levels and tumor grade (r = 0.48, p = 0.0002). We have also examined the effect of the RyR agonist 4-chloro-m-cresol on the in-vitro growth of two human breast cancer cell lines, MCF-7 and MDA-MB-231. Treatment with 4-chloro-m-cresol ...
Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade. MA Fonseca-Sánchez,SR Cuevas,G Mendoza-Hernández,... - Spandidos Publications 被引量: 0发表: 2012年 Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are...
RESULTS: Over 15 + years of follow-up, PAM50 subtypes were (P < 0.01) associated with breast cancer outcomes after accounting for tumor stage, grade and age at diagnosis. Results did not differ by menopausal status at diagnosis. Women with Luminal B (versus Luminal A) subtype had a > 60...
In early-stage breast cancer, where the use of systemic therapy has to be determined for every patient, the three main prognostic determinants used in routine practice are lymph node (LN) status, tumor size, and histological grade. The Nottingham (Elston-Ellis) modification of the Scarff-Bloom...
According to the American Joint Committee on Cancer (AJCC) guidelines, Neo-Bioscore is calculated by considering for each patient the pretreatment clinical stage and the post-treatment pathologic stage.26 Additional points are added in case of ER-negative disease, nuclear grade 3 tumours, and HER2...